🇺🇸 FDA

Company profile · Sponsor

Xenetic

Xenetic Biosciences

XBIO · NYSE pharma FRAMINGHAM, MA, USA
Pipeline
1
Drugs
0
Patents
1

Quick answer

Xenetic (XBIO) is a pharma company. headquartered in FRAMINGHAM, MA, USA. listed on NYSE. NovaPharmaNews links 1 pipeline program, 0 drugs, and 1 patent to this profile..

Company facts

Ticker XBIO
Exchange NYSE
Company type pharma
Headquarters FRAMINGHAM, MA, USA
SEC CIK 0001534525

Pipeline (1)

Search pipeline →

  1. Sodium Cridanimod

    Xenetic

    Endometrial Cancer

    phase 2 small molecule terminated

    1 trial

Patents (1)

Search patents →

  1. US 10188739

    Compositions and methods for administering insulin or insulin-like protein to the brain

    Expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Xenetic?

Xenetic (XBIO) is a pharma company. headquartered in FRAMINGHAM, MA, USA. listed on NYSE. NovaPharmaNews links 1 pipeline program, 0 drugs, and 1 patent to this profile..

What pipeline programs does Xenetic sponsor?

We track 1 ClinicalTrials.gov-linked program for Xenetic, including Sodium Cridanimod. Open each program for phase, modality, NCT IDs, and indication details.

Where does Xenetic company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.